Medip Analytics translates clinical and economic evidence into clear, locally relevant insight — giving hospitals, payers, and policymakers the confidence to evaluate new technologies, and innovators the tools to prove their value where it counts.
Trusted by


















Medip Academy is live. Explore the training platform for guided courses on software usage and health economic principles.
Diagnostic AI, medtech, biotech, and pharma companies often lose momentum after clinical validation or regulatory approval. Decision-makers still need to understand how the evidence holds up in a changing local environment:
“What is the real impact for my specific organization?”
Markets shift, assumptions remain uncertain, care pathways are complex, and stakeholders do not always define value in the same way. That is where implementation slows.
Medip Analytics turns scientific and epidemiological data into adaptable models that quantify clinical, operational, and economic value for each stakeholder perspective.
Discover how Medip Analytics helps make the value and impact of new technologies clearer for all stakeholders involved.
Use one platform to help patients, healthcare professionals, hospital managers, payers, and policymakers assess the same innovation through locally relevant evidence.
Show patient outcomes, clinical outcomes, and where your innovation fits in daily care so healthcare professionals can adopt new innovation with confidence.
Show local budget impact, efficiency gains, capacity effects, and what adoption means for the organisation and pharmacy workflow.
Support reimbursement decisions and conditions, and support commissioning and contracting.
Support guideline inclusion and estimate the long-term policy impact of adoption.
Present the outcomes that matter most to each stakeholder, even when the decision context is complex and uncertainty remains.
Show what changes for patients and how your innovation affects care decisions.
Show the local financial effect for hospitals, regions, and health systems.
Show whether the innovation delivers value for money in a specific context.
Show where the investment pays back for providers and healthcare systems.
Show how adoption affects capacity, patient flow, and daily operations.
Show broader value beyond direct healthcare costs and outcomes.
Medip Analytics is a health economic platform for diagnostic AI, medtech, biotech, and pharma. It helps translate clinical evidence into local evidence for hospitals, payers, healthcare professionals, and policymakers.
The platform can demonstrate clinical outcomes, budget impact, cost-effectiveness, return on investment, workflow impact, and broader societal or environmental effects.
It is designed for teams in diagnostic AI, diagnostics, medtech, biotech, and pharma that need to demonstrate clinical, operational, and economic impact in a way that is relevant to hospitals, payers, policymakers, and healthcare professionals.
HEOR stands for Health Economics and Outcomes Research. It focuses on showing how a product affects outcomes, costs, and resource use in real-world care.
HTA stands for Health Technology Assessment. It is the structured evaluation of a health technology to support decisions about adoption, reimbursement, and use in practice.
Medip Analytics is based in Nijmegen, The Netherlands. The company is led by Tim Govers, PhD, CEO and HTA expert, and Stan Wijn, PhD, CTO and modeling and software expert.
Join the discussion
Discuss how the platform can help different stakeholders assess new technologies with clearer, locally relevant evidence.